Prohibited substance cases under FEI anti-doping rules

27 Nov 2018
27 Nov 2018 Author: ONI

The FEI has announced three adverse analytical findings (AAF) involving Prohibited Substances in one human and two equine cases.

The equine cases involve *Banned Substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

The athletes have been provisionally suspended from the date of notification until the FEI Tribunal renders its decisions. The horses have been provisionally suspended for two months.

Horse: Veni Vidi Vici (FEI ID 102MJ29/JOR)
Person Responsible: Huda Kayali (FEI ID 10081862/JOR)
Event: CSIY-B - Amman (JOR), 18-19.10.2018
Prohibited Substance(s): Stanozolol, 16-beta-hydroxystanozolol, Phenylbutazone, Oxyphenbutazone
Date of notification: 13 November 2018

Horse: Orient Akhmin (FEI ID 104WR20/ UAE)
Person Responsible: Adel Mohd Ali Al Housani (FEI ID 10055482/ UAE)
Event: CEI1* 80 - Abu Dhabi, Al Wathba (UAE), 27.10.2018
Prohibited Substance(s): Testosterone
Date of notification: 13 November 2018

The human case involves two Prohibited Substances under the FEI’s Anti-Doping Rules for Human Athletes (ADRHA).

The athlete has been provisionally suspended from the date of notification until the FEI Tribunal renders its decision.

Athlete: Jan-Philipp Weichert (FEI ID: 10072662/GER)
Event: CSI2* - Balve (GER), 7-10 June 2018
Prohibited Substance(s): Cocaine metabolite Benzoylecgonine, Amfetamine
Date of notification: 13 November 2018

Details on all these cases can be found here.

Separately, the FEI Tribunal has issued Final Decisions in three cases involving Banned Substances.

The cases are: Golden Boy (FEI ID 104IU95/IND), ridden by Indian athlete Raj Kumar (FEI ID 10107326/IND); Cantolina (FEI ID 105PG73/IND), ridden by Indian athlete Apurva Dabhade (FEI ID 10113752/IND); and Black Beauty (FEI ID 105WE15/IND), ridden by Indian athlete Sarvesh Singh Pal (FEI ID 10161986/IND).

All three cases involve the substance Boldenone, which was detected in samples taken from the horses at the CCI1* in Delhi (IND) on 27-30 November 2017. The horse Black Beauty also tested positive to the Controlled Medication substance Meloxicam.

All three athletes have been suspended for two years from the date of notification of the adverse analytical findings (9 January 2018) until 8 January 2020. The three horses were provisionally suspended for two months from the date of notification. None of the athletes will be charged legal costs, but fines were levied on each of them.

The athletes have 21 days to appeal the decisions to the Court of Arbitration for Sport (CAS) from the dates of notification of the Final Decisions (9 November 2018).

The FEI Tribunal’s decisions can be found here.


FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse. In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Banned Substance which is also a **Specified Substance). The horse is suspended for two months. Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.

**Specified Substances

The FEI introduced the concept of Specified Substances in 2016. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances (i.e. whether Banned or Controlled). Rather, they are simply substances which are more likely to have been ingested by horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance.